Drug: Sufentanil: chronic pain clinical trials
Registry records that list "Drug: Sufentanil" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lung Resection NCT07018375 | Recruiting | Phase 4 | China | Tianjin Medical University General Hospital | 2026-01-06 |
| Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes NCT05718544 | Completed | Phase 4 | China | Peking University First Hospital | 2023-01-30 |
| Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population NCT04464512 | Withdrawn | Phase 4 | United States | West Virginia University | 2020-01-10 |
| A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer NCT00943566 | Withdrawn | Phase 2 | Labtec GmbH | 2010-01 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.